Colnova 0.5 0,5 mg Tablet
PDF Leaflet Revision Date: 04 April 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of acute attacks of gout.
Dosage (summary)
0.5 to 1 mg (1-2 tablets) immediately, then 0.5 mg (1 tablet) every 2 hours until relief or max 6 mg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- P-gp inhibitors
- Grapefruit juice
Contraindications
- Hypersensitivity to colchicine
- Severe renal impairment
- Severe hepatic impairment
- Blood disorders
Common side effects
- Nausea
- Vomiting
- Abdominal pain
- Diarrhoea
Counselling Points
- Avoid exceeding prescribed dose
- Monitor for gastrointestinal symptoms
- Use effective contraception in women of childbearing potential
Serious warnings
- Narrow therapeutic window
- Potential for fatal overdose
- Bone marrow suppression
Important Disclaimer
The Colnova 0.5 0,5 mg Tablet professional information leaflet below is the property of Novagen Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
